Corcept Therapeutics Incorporated
CORT
$33.27
-$0.04-0.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.43% | -25.18% | 6.09% | 13.53% | 33.04% |
| Total Depreciation and Amortization | 41.47% | 62.72% | 101.49% | -3.75% | -43.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 309.39% | 747.67% | 70.03% | 26.27% | -0.91% |
| Change in Net Operating Assets | -103.09% | 266.31% | 362.26% | 656.62% | 453.97% |
| Cash from Operations | -28.39% | 13.52% | 47.42% | 43.92% | 56.09% |
| Capital Expenditure | 90.29% | 86.25% | -323.18% | -1,537.41% | -1,462.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 139.88% | 118.62% | 75.49% | -35.11% | -292.69% |
| Cash from Investing | 139.28% | 117.93% | 74.37% | -36.77% | -295.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 165.08% | 152.22% | 163.79% | 86.87% | 65.48% |
| Repurchase of Common Stock | -547.59% | -576.48% | -1,282.64% | 49.21% | 75.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -677.33% | -741.54% | -2,781.96% | 54.76% | 80.94% |
| Foreign Exchange rate Adjustments | 732.46% | 35.09% | 26,300.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.08% | -147.67% | 40.98% | 60.10% | -111.39% |